DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Chlorpheniramine polistirex; codeine polistirexis the generic ingredient in three branded drugs marketed by Lannett Co Inc, Fisons, and Aytu, and is included in three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Chlorpheniramine polistirex; codeine polistirex has twenty-one patent family members in fourteen countries.
There are twenty-nine drug master file entries for chlorpheniramine polistirex; codeine polistirex. One supplier is listed for this compound.
Summary for chlorpheniramine polistirex; codeine polistirex
|Drug Master File Entries:||29|
|Suppliers / Packagers:||1|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for chlorpheniramine polistirex; codeine polistirex|
|DailyMed Link:||chlorpheniramine polistirex; codeine polistirex at DailyMed|
Pharmacology for chlorpheniramine polistirex; codeine polistirex
|Drug Class||Histamine-1 Receptor Antagonist |
|Mechanism of Action||Histamine H1 Receptor Antagonists |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Fisons||PENNTUSS||chlorpheniramine polistirex; codeine polistirex||SUSPENSION, EXTENDED RELEASE;ORAL||018928-001||Aug 14, 1985||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Aytu||TUZISTRA XR||chlorpheniramine polistirex; codeine polistirex||SUSPENSION, EXTENDED RELEASE;ORAL||207768-001||Apr 30, 2015||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Lannett Co Inc||CODEPREX||chlorpheniramine polistirex; codeine polistirex||SUSPENSION, EXTENDED RELEASE;ORAL||021369-001||Jun 21, 2004||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Fisons||PENNTUSS||chlorpheniramine polistirex; codeine polistirex||SUSPENSION, EXTENDED RELEASE;ORAL||018928-001||Aug 14, 1985||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.